Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
61 Cards in this Set
- Front
- Back
form of H bonds btwn ssRNA/DNA that are comple
|
n acid hybridization
|
|
btwn 2 polynucl chains which have compl bases
principle: at incr temp, dsDNA will denature > ssDNA, whn decr emp, strands anneal due to bp |
intermolecular hybridiz
|
|
ssRNA/DNA oligonucl labeled with a reporter chem
will hypridize to target n.a. on the basis of bp |
probe
|
|
DNA/RNA is immobilized on inert support so that self annealing is prevented
bound seq are available for hybrid with added probe use filter paper (mc) |
solid support hybrid
|
|
typer of solid support hybrid
|
S blot
Dot/slot blot N blot |
|
procedure for transf denatured DNA form an ag. gel to a solid support filter where it can be hybridized with a compl n.a. probe
DNA sep by size so that spec frags can be identified DNA only |
S blot
|
|
S blot commonly used to
|
ident spec seq of DNA in which the frags are sep by electro> a memb and ident with probe
detects restric frags to screen DNA and cDNA libraries |
|
to study gene expr with RNA
sep RNA Pattern > nylon memb hybridize with 1 probe only and need separate blot for each probe tested |
N blot
|
|
for multiple gene expr at once
thousands of probes on slide/memb target is cDNA/mRNA fluor labeled probe/target monitors activity of genes by mRNA hybridiz |
Micro array
|
|
DNA/RNA bound directly to solid filter
no size sep for mult samples and quantity |
dot/slot blot
|
|
id spec translocation breaks, chrom del, and gene amp
for solid tumor study |
FISH
|
|
target n.a. is ampl
|
PCR
NASBA TMA SDA |
|
signal is ampl
|
HC2
bDNA |
|
probe is ample
|
bDNA
|
|
ampl DNA
thermal cycling req: target, primers, Taq, buffer, dNTP |
PCR
|
|
most sensitive for mRNA
starts with RT, mRNA> cDNA |
RT PCR
|
|
simul ampl and quant target DNA
Taq man probe= reporter |
Real TIme PCR
|
|
2 or more mRNA targets at once
|
Multiplex PCR
|
|
to determine order of nucl bases of DNA
Sanger method and maxam gilbert method |
DNA seq
|
|
polymer chain is term with ddNTPs labeled with diff colors, detected by laser
|
Sanger method
DNA seq |
|
detects spec proteins in sample
uses SDS PAGE to sep denatured proteins by length uses 2ndary ab with color/chemil enzyme for confirm of HIV, Mad cow, lyme disease |
W blot
|
|
ideal candidates for blood genotyping
|
Sickle cell
Thall H anemia lekemia pst transf/ pos DAT incr incidince ag for ID |
|
acceptable samples for genotyping
|
EDTA blood
cheeck swab- babies and aplastic pts leukored filters |
|
ideal donors for genotyping
|
based on dempgraphic area
Blacks for sickle cell pts screen for rares |
|
when to genotype
|
prior to transf
to obtain extended pheno post transf ab ID DAT pos |
|
why genotyping is done in blood bank
|
can incr donors by genot screening
incr care and TAT for pts to find more accurate match fro discrep and rare ab |
|
gold std for mol diag
|
N.a. ampl
|
|
use known n.a. probe labeled with detector to hybrib to another n.a. with bp
rapid, simple, cheap, accurate req large number of orgs |
non ampl N.a. probes
|
|
single/few copies of DNA/RNA are ampl by enzyme under direction of primer
rapid, sensitive, accurate need extra sample prep, false pos |
target ampl
|
|
target ampl methods
|
PCR
NASBA TMA SDA for N. gon, C. trach, M. tuber, HBV, HCV, HIV, CMV |
|
isothermal n.a. ampl based of restr enzyme and polym
for N. gon and C. trach target1 |
SDA
|
|
signal ampl methods
|
bDNA
HC2 |
|
target n.a. seq not repl but ampl signal from probe
FDA abbroved for HIV and HCV |
bDNA
|
|
signal ampl after hybrid of target DNA with RNA probe
incr sensitivity FDA cleared for HPV |
HC2
|
|
size of entire plasmid.chrom is determined
for genotyping or genetic fingerprint gold std for patho orgs |
PFGE/ DNA fingerprint
|
|
direct seq is determined, most accurate
for HepC |
N.a. seq
|
|
Lim of N.a. ampl
|
expensive
needed trained techs contam is easy rigid QC need confirm test |
|
DNA is pos, org is absent
can be after antimicrobial therapy (C. trach and B. pert), gene present but not expressed (B. pert), gene present but unable to distiguish from normal flora ( S. pneumo) |
Clinical false pos, good
|
|
from contam
cross reactivity |
Analytical false pos, bad
|
|
can be caused by Norovirus, org rapidly cleared, DNA lost during processing, ampl inhibition
|
False neg
|
|
for detecting or correcting defects by estab limits of acceptable performance
|
QC
|
|
for continuing monitoring and improving the reliability, efficiency, and clinical value of lab tests
to decr and prevent errors CLIA 88, CLSI, ACMG, CAP |
QA
|
|
QA can be done
|
in pre analyt, analyt, and post analyt of specimen processing
|
|
to prevent contam/carry over
|
good lab practice
sep pre and pst ampl PPE one way work flow |
|
poor collection or wrong source
|
False neg, good
|
|
poor PCR design, inhib PCR, PCR error
|
False neg, bad
|
|
techs for Fragile X
|
RFLP
S. blot PCR with RE methylation |
|
techs for CF
|
targeted/scanning mutation analysis with PCR
panel sensitivity |
|
CF
|
CFTR mutation, F508 del is m.c.
|
|
Fragile X
|
trinucl repeat expansions of CGG on FMR-1 gene of X
mc form of inherited mental retardation more Males |
|
Polymorphism
|
germ line changes
in 1% of popl RFLP VNTR STR SNP |
|
mini satellite repeats
for DNA fingerprinting |
VNTR
|
|
micro satellite repeats of CA, highly suscep to mutation when DNA repair mech lost
use PCR and tumor testing |
STR
|
|
single nucl variations
detect with PCR or DNA Chip |
SNP
|
|
for BRAF/KRAS
|
sequencing, RT-PCR, hybridiz (Dot blot)
|
|
for HER2
|
FISH
|
|
for HPV
|
HC2, cervical swab, PCR/tumor spec
|
|
causes 67% of melanoma
v600E= 90% of mutations caused by GAG mutation |
BRAF
|
|
mutations prevent GTP hydrolysis= always on > incr repl
most mutations in codons 12,13,61 on chrom 12 G>T = Val instead of Gly > abn growth |
KRAS
|
|
predisp of BRAC1, 2 genes
predict with HER2 ampl target FISH- fluor prob on tissue |
breast cancer
|
|
all contain HPV DNA
HPV 16, 18, 31= 95% use HC2, signal ampl detects but doesnt distinguish |
Cervical cancer
|